SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Alcobra Ltd.
(NASDAQ : ADHD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-3.72%22.273.5%$556.63m
SHPGShire PLC Sponsored ADR
1.41%194.120.4%$261.63m
RLYPRelypsa, Inc.
-0.19%31.9427.7%$165.70m
PRGOPerrigo Co. Plc
0.34%91.393.1%$161.87m
JAZZJazz Pharmaceuticals Plc
-1.21%150.973.1%$119.12m
ENDPEndo International Plc
-2.96%17.365.6%$103.08m
ICPTIntercept Pharmaceuticals, Inc.
3.67%173.0312.8%$84.22m
MNKMallinckrodt Plc
0.00%67.349.0%$81.94m
UTHRUnited Therapeutics Corporation
1.70%121.0115.4%$68.27m
SAGESAGE Therapeutics, Inc.
0.13%44.868.4%$61.20m
HZNPHorizon Pharma plc
-1.68%19.2911.8%$60.04m
ALRAlere Inc.
2.63%37.524.6%$57.82m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.00%94.327.7%$45.22m
ICLRICON Plc
-1.30%77.674.6%$41.24m
MDCOMedicines Company
0.57%39.1119.2%$39.86m

Company Profile

Alcobra Ltd. engages in the development and commercialization of proprietary pharmaceutical products for the treatment of central nervous system disorders and cognitive dysfunctions. Its proprietary oral drug candidate, Metadoxine Extended Release, to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.